Organon (OGN) Change in Account Payables (2020 - 2026)

Organon (OGN) posted quarterly Change in Account Payables of $32.0 million for Q1 2026, up 121.48% year-over-year from $14.4 million in Q1 2025, and up 126.67% on a QoQ basis from -$120.0 million in Q4 2025.

Organon (OGN) Change in Account Payables (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Change in Account Payables for 7 consecutive years, with $32.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Account Payables rose 121.48% year-over-year to $32.0 million; the TTM figure through Mar 2026 stood at -$36.0 million (down 183.72% YoY), while the FY2025 annual figure was -$217.0 million, down 38.22% from the prior year.
  • Change in Account Payables came in at $32.0 million for Q1 2026 at Organon, up from -$120.0 million in the prior quarter.
  • The five-year high for Change in Account Payables was $293.0 million in Q2 2024, with the low at -$349.0 million in Q1 2024.
  • Average Change in Account Payables over 5 years is -$24.5 million, with a median of $12.0 million recorded in 2025.
  • Across the five-year window, Change in Account Payables sank 7550.0% in 2022 and soared 168.6% in 2023, its largest moves.
  • Year by year, Change in Account Payables stood at $86.0 million in 2022, then soared by 168.6% to $231.0 million in 2023, then tumbled by 74.89% to $58.0 million in 2024, then sank by 306.9% to -$120.0 million in 2025, then soared by 126.67% to $32.0 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered $32.0 million, -$120.0 million, and $12.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 571.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -67.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 32.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.00 Mn
Mar 31, 2026 32.00 Mn
Dec 31, 2025 -120.00 Mn
Dec 31, 2025 -120.00 Mn
Sep 30, 2025 12.00 Mn
Sep 30, 2025 12.00 Mn
Jun 30, 2025 40.00 Mn
Jun 30, 2025 40.00 Mn
Mar 31, 2025 -149.00 Mn
Mar 31, 2025 -149.00 Mn
Dec 31, 2024 58.00 Mn
Dec 31, 2024 58.00 Mn
Sep 30, 2024 -159.00 Mn
Sep 30, 2024 -159.00 Mn
Jun 30, 2024 293.00 Mn
Jun 30, 2024 293.00 Mn
Mar 31, 2024 -349.00 Mn
Mar 31, 2024 -349.00 Mn
Dec 31, 2023 231.00 Mn
Dec 31, 2023 231.00 Mn